pindolol has been researched along with Depression, Endogenous in 74 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following on from the suggestion that nefazodone, a specific serotonin reuptake inhibitor and antagonist of 5-HT2, improves 5-HT1A-mediated transmission, we used a pindolol and nefazodone combination treatment for major depressive disorder." | 7.69 | Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. ( Bakish, D; Hooper, CL; Miller, CA; Thibaudeau, CA; Thornton, MD; Wiens, A, 1997) |
| "We describe the successful treatment of five patients with treatment-resistant major depressive disorder (TR-MDD) with a combination pharmacotherapy of pindolol, tryptophan and nefazodone." | 5.09 | The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder. ( Devarajan, S; Dursun, SM; Kutcher, S, 2001) |
| "The binding of [125I]p-iodoclonidine to alpha-2, and/or [125I]iodopindolol to beta-1 and beta-2 adrenoceptors was measured in right prefrontal cortex (Brodmann's area 10) and right hippocampus from subjects with DSM-III-R diagnoses of major depression (n = 15) or schizophrenia (n = 8) as well as from control subjects (n = 20)." | 3.70 | Brain noradrenergic receptors in major depression and schizophrenia. ( Dilley, G; Klimek, V; Luker, SN; Meltzer, HY; Ordway, GA; Overholser, JC; Rajkowska, G; Stockmeier, CA, 1999) |
| " Following on from the suggestion that nefazodone, a specific serotonin reuptake inhibitor and antagonist of 5-HT2, improves 5-HT1A-mediated transmission, we used a pindolol and nefazodone combination treatment for major depressive disorder." | 3.69 | Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. ( Bakish, D; Hooper, CL; Miller, CA; Thibaudeau, CA; Thornton, MD; Wiens, A, 1997) |
| "Pindolol has been widely investigated as an augmenter of antidepressant drug response." | 2.77 | A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression. ( Bech, P; Lunde, M; Martiny, K; Plenge, P, 2012) |
| "5 mg/day or placebo for nine days in combination with three consecutive TSD cycles." | 2.69 | Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. ( Barbini, B; Benedetti, F; Campori, E; Colombo, C; Smeraldi, E, 1999) |
| "Pindolol has been reported to hasten the antidepressant action of selective serotonin reuptake inhibitors in open-label and placebo-controlled trials." | 2.69 | A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. ( Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J, 1999) |
| "Pindolol treatment was associated with statistically significant reduction in blood pressure and pulse as compared to the control group." | 2.69 | The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. ( Anand, A; Berman, RM; Cappiello, A; Charney, DS; Hu, XS; Miller, HL; Oren, DA, 1999) |
| " The aim of the present study was to examine whether pindolol may increase the efficacy of a subtherapeutical dosage of trazodone in the treatment of major depression and TRD, defined according to the Thase and Rush criteria (1995)." | 2.68 | Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. ( Desnyder, R; Maes, M; Vandoolaeghe, E, 1996) |
| "Pindolol was well tolerated by all patients." | 2.68 | Pindolol augmentation of treatment-resistant depressed patients. ( Bachar, K; Delgado, PL; Gelenberg, AJ; Moreno, FA, 1997) |
| "Pindolol tended to attenuate seizure duration, especially at the 10 mg dose." | 2.67 | Prolactin and thyrotropin responses to ECT after pindolol administration. A placebo controlled study. ( Lykouras, L; Markianos, M; Papadimitriou, G; Papakostas, Y; Stefanis, C; Stefanis, N, 1993) |
| "Despite the prevalence and morbidity of bipolar depression, few randomized treatment trials have been conducted to assess clinical efficacy." | 2.42 | Acceleration and augmentation strategies for treating bipolar depression. ( Altshuler, LL; Frye, MA; Gitlin, MJ, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.41) | 18.7374 |
| 1990's | 47 (63.51) | 18.2507 |
| 2000's | 20 (27.03) | 29.6817 |
| 2010's | 3 (4.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whale, R | 1 |
| Terao, T | 2 |
| Cowen, P | 1 |
| Freemantle, N | 1 |
| Geddes, J | 1 |
| de Diego-Adeliño, J | 1 |
| Portella, MJ | 1 |
| Puigdemont, D | 2 |
| Pérez-Egea, R | 1 |
| Alvarez, E | 4 |
| Pérez, V | 3 |
| Martiny, K | 1 |
| Lunde, M | 1 |
| Bech, P | 1 |
| Plenge, P | 1 |
| Altshuler, LL | 1 |
| Frye, MA | 1 |
| Gitlin, MJ | 1 |
| Isaac, MB | 2 |
| Isaac, MT | 8 |
| Gallo, F | 1 |
| Tournoux, A | 1 |
| Ballesteros, J | 1 |
| Callado, LF | 1 |
| Rabiner, EA | 1 |
| Bhagwagar, Z | 1 |
| Gunn, RN | 1 |
| Cowen, PJ | 1 |
| Grasby, PM | 1 |
| Lemonde, S | 1 |
| Du, L | 1 |
| Bakish, D | 2 |
| Hrdina, P | 1 |
| Albert, PR | 1 |
| Booij, L | 1 |
| Van der Does, AJ | 1 |
| Haffmans, PM | 1 |
| Riedel, WJ | 1 |
| Carvalho, AF | 1 |
| Cavalcante, JL | 1 |
| Castelo, MS | 1 |
| Lima, MC | 1 |
| Artigas, F | 6 |
| Blier, P | 5 |
| Bergeron, R | 3 |
| Howland, RH | 2 |
| Little, KY | 2 |
| Clark, TB | 2 |
| Ranc, J | 2 |
| Duncan, GE | 1 |
| Papakostas, Y | 1 |
| Markianos, M | 1 |
| Papadimitriou, G | 1 |
| Stefanis, N | 1 |
| Lykouras, L | 1 |
| Stefanis, C | 1 |
| Anderson, GM | 1 |
| Romero, L | 1 |
| de Montigny, C | 2 |
| Maes, M | 4 |
| Van de Vyvere, J | 1 |
| Vandoolaeghe, E | 3 |
| Bril, T | 1 |
| Demedts, P | 2 |
| Wauters, A | 2 |
| Neels, H | 2 |
| Werstiuk, ES | 1 |
| Coote, M | 1 |
| Griffith, L | 1 |
| Shannon, H | 1 |
| Steiner, M | 1 |
| Desnyder, R | 1 |
| Berman, RM | 2 |
| Darnell, AM | 1 |
| Miller, HL | 2 |
| Anand, A | 2 |
| Charney, DS | 3 |
| Van Hunsel, F | 2 |
| Gilmore, J | 1 |
| Patel, A | 1 |
| Kraus, RP | 2 |
| Tome, MB | 6 |
| Harte, R | 1 |
| Holland, C | 1 |
| Hooper, CL | 1 |
| Thornton, MD | 1 |
| Wiens, A | 1 |
| Miller, CA | 1 |
| Thibaudeau, CA | 1 |
| Cloninger, CR | 1 |
| Watson, JP | 1 |
| Bordet, R | 2 |
| Thomas, P | 2 |
| Dupuis, B | 2 |
| Moreno, FA | 1 |
| Gelenberg, AJ | 1 |
| Bachar, K | 1 |
| Delgado, PL | 1 |
| Zanardi, R | 4 |
| Franchini, L | 1 |
| Sforzini, L | 1 |
| Gasperini, M | 1 |
| Smeraldi, E | 5 |
| Perez, J | 2 |
| Sussman, N | 2 |
| Joffe, RT | 2 |
| Thase, ME | 1 |
| Friedman, ES | 1 |
| Nelson, JC | 3 |
| Benedetti, F | 2 |
| Di Bella, D | 1 |
| Catalano, M | 1 |
| McAllister-Williams, RH | 1 |
| Young, AH | 1 |
| McAskill, R | 1 |
| Mir, S | 1 |
| Taylor, D | 1 |
| Barbini, B | 1 |
| Campori, E | 1 |
| Colombo, C | 1 |
| Soler, J | 1 |
| Libbrecht, I | 1 |
| Campens, D | 1 |
| Meltzer, HY | 2 |
| Cappiello, A | 1 |
| Hu, XS | 1 |
| Oren, DA | 1 |
| Klimek, V | 1 |
| Rajkowska, G | 1 |
| Luker, SN | 1 |
| Dilley, G | 1 |
| Overholser, JC | 1 |
| Stockmeier, CA | 1 |
| Ordway, GA | 1 |
| Goodman, WK | 1 |
| Fava, M | 1 |
| Sacristán, JA | 1 |
| Gilaberte, I | 1 |
| Boto, B | 1 |
| Buesching, DP | 1 |
| Obenchain, RL | 1 |
| Demitrack, M | 1 |
| Pérez Sola, V | 1 |
| Shiah, IS | 1 |
| Yatham, LN | 1 |
| Srisurapanont, M | 1 |
| Lam, RW | 1 |
| Tam, EM | 1 |
| Zis, AP | 2 |
| Tamura, RN | 1 |
| Faries, DE | 1 |
| Feng, J | 1 |
| Coryell, W | 1 |
| Olver, JS | 1 |
| Cryan, JF | 1 |
| Burrows, GD | 1 |
| Norman, TR | 1 |
| Dursun, SM | 1 |
| Devarajan, S | 1 |
| Kutcher, S | 1 |
| Serretti, A | 2 |
| Rossini, D | 2 |
| Cusin, C | 2 |
| Lilli, R | 2 |
| Chaouloff, F | 1 |
| Lattuada, E | 1 |
| Lorenzi, C | 1 |
| Goumeniouk, AD | 1 |
| Clark, CM | 1 |
| Remick, RA | 1 |
| Adams, SA | 1 |
| Mazzola, P | 2 |
| Jeanningros, R | 2 |
| Azorin, JM | 2 |
| Aligne, L | 1 |
| Tissot, R | 2 |
| Samuelian-Massa, C | 1 |
| Magliozzi, JR | 1 |
| Gietzen, D | 1 |
| Maddock, RJ | 1 |
| Haack, D | 1 |
| Doran, AR | 1 |
| Goodman, T | 1 |
| Weiler, PG | 1 |
| Pandey, GN | 1 |
| Janicak, PG | 1 |
| Davis, JM | 1 |
| Brown, SL | 1 |
| Woods, SW | 1 |
| Heninger, GR | 1 |
| Tallman, J | 1 |
| Graafsma, S | 1 |
| Rodrigues de Miranda, J | 1 |
| Thien, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Short Term Double Blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression[NCT00159146] | 31 participants (Actual) | Interventional | 2002-08-31 | Terminated (stopped due to lack of participants fulfilling inclusion criteria) | |||
| Imaging Serotonin 5-HT1A Receptors in the High Affinity State in Brains of Patients With Major Depressive Disorder[NCT01313403] | 0 participants (Actual) | Interventional | 2011-02-10 | Withdrawn | |||
| Implementation of Dialectical Behavioral Therapy in Juvenile Justice to Reduce Self-Harm and Increase Quality of Life: A Pilot Test[NCT05583279] | 300 participants (Anticipated) | Interventional | 2023-09-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for pindolol and Depression, Endogenous
| Article | Year |
|---|---|
Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder; Drug Int | 2010 |
Acceleration and augmentation strategies for treating bipolar depression.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar | 2003 |
Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; | 2004 |
Augmentation strategies for treatment-resistant depression: a literature review.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Buspirone; Central Ne | 2007 |
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Pindolol; Piperazines; Pyridines; Serotonin Anta | 1996 |
Treating antidepressant nonresponders with augmentation strategies: an overview.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy | 1998 |
The use of pindolol to potentiate antidepressant medication.
Topics: Animals; Antidepressive Agents; Autoreceptors; Controlled Clinical Trials as Topic; Depressive Disor | 1998 |
Treatment of antidepressant nonresponders: augmentation or switch?
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Drug Administration | 1998 |
Overcoming treatment resistance in depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Resistance | 1998 |
Pindolol augmentation of antidepressant therapy.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Controlled Clinical Trials as Topic; Depressive | 1998 |
Obsessive-compulsive disorder: diagnosis and treatment.
Topics: Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Comorbidit | 1999 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; M | 2000 |
Augmentation strategies in depression 2000.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Depressive | 2000 |
Pindolol augmentation of antidepressants: a review and rationale.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Drug Synergism; Drug Therapy, | 2000 |
Pharmacology of rapid-onset antidepressant treatment strategies.
Topics: Antidepressive Agents, Tricyclic; Autoreceptors; Cyclohexanols; Depressive Disorder; Drug Synergism; | 2001 |
29 trials available for pindolol and Depression, Endogenous
| Article | Year |
|---|---|
A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes.
Topics: Adult; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Femal | 2010 |
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.
Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Desvenlafaxine Succinat | 2012 |
Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Adult; Age Factors; Cyclopropanes; Depressive Disord | 2003 |
Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Met | 2003 |
Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
Topics: Adrenergic beta-Antagonists; Adult; Autoreceptors; Depressive Disorder; Dose-Response Relationship, | 2004 |
Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.
Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; | 1995 |
Prolactin and thyrotropin responses to ECT after pindolol administration. A placebo controlled study.
Topics: Adult; Aged; Analysis of Variance; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; M | 1993 |
Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process.
Topics: Acute-Phase Reaction; Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents, Second-Genera | 1996 |
Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Dru | 1996 |
Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Double-Blind Method; Drug Interaction | 1997 |
Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.
Topics: Acute-Phase Proteins; Adrenergic beta-Antagonists; Adult; Aged; Alpha-Globulins; Antidepressive Agen | 1996 |
Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Dou | 1997 |
Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
Topics: Adrenergic beta-Agonists; Adult; Depressive Disorder; Double-Blind Method; Ego; Female; Humans; Male | 1997 |
Selective serotonin reuptake inhibitors plus pindolol.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans | 1997 |
Pindolol augmentation of treatment-resistant depressed patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ambulatory Care; Depressive Disorder; Double-Blind Method; | 1997 |
How long should pindolol be associated with paroxetine to improve the antidepressant response?
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; | 1997 |
One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studie | 1998 |
Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo.
Topics: Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Paroxeti | 1998 |
Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
Topics: Adrenergic beta-Antagonists; Adult; Depressive Disorder; Double-Blind Method; Drug Interactions; Dru | 1998 |
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Topics: Antidepressive Agents, Second-Generation; Carrier Proteins; Depressive Disorder; Drug Therapy, Combi | 1998 |
Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Affect; Bipolar Disorder; Combined Modality Thera | 1999 |
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; | 1999 |
Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
Topics: Adult; Aged; Analysis of Variance; Depressive Disorder; Fluoxetine; Humans; Mianserin; Middle Aged; | 1999 |
The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Pind | 1999 |
Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Depressive Disorder; Double- | 2000 |
Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study.
Topics: Adrenergic beta-Antagonists; Adult; Combined Modality Therapy; Depressive Disorder; Double-Blind Met | 2000 |
The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder; Drug Resistanc | 2001 |
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
Topics: Adult; Age of Onset; Alleles; Antidepressive Agents, Second-Generation; Bipolar Disorder; Carrier Pr | 2001 |
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive | 2002 |
30 other studies available for pindolol and Depression, Endogenous
| Article | Year |
|---|---|
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Ge | 2004 |
Acute tryptophan depletion in depressed patients treated with a selective serotonin-noradrenalin reuptake inhibitor: augmentation of antidepressant response?
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Female; Human | 2005 |
Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Humans; Monoamine Ox | 1995 |
Biochemical effects of antidepressant augmentation.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Hu | 1995 |
Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.
Topics: Adult; Aged; Animals; Depressive Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Monoam | 1994 |
Beta-adrenergic receptor binding in frontal cortex from suicide victims.
Topics: Adolescent; Adult; Aged; Cause of Death; Depressive Disorder; Female; Frontal Lobe; Humans; Male; Mi | 1993 |
Comments on "Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression".
Topics: Adrenergic beta-Antagonists; Depressive Disorder; Drug Synergism; Humans; Pindolol; Selective Seroto | 1996 |
Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
Topics: Adult; Aged; Blood Platelets; Depressive Disorder; Down-Regulation; Electroconvulsive Therapy; Femal | 1996 |
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 1997 |
Lack of pineal beta-adrenergic receptor alterations in suicide victims with major depression.
Topics: Adult; Aged; Autoradiography; Depressive Disorder; Female; Humans; Male; Melatonin; Middle Aged; Nor | 1997 |
Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
Topics: Adult; Antidepressive Agents, Second-Generation; Arousal; Bipolar Disorder; Depressive Disorder; Dos | 1996 |
Pindolol augmentation of tranylcypromine in psychotic depression.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combin | 1997 |
Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; D | 1997 |
Selective serotonin reuptake inhibitors plus pindolol. The REEP.
Topics: Depressive Disorder; Fluoxetine; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibito | 1997 |
Selective serotonin reuptake inhibitors plus pindolol.
Topics: Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Pindolol; Selective Serotonin Reuptake I | 1997 |
Pindolol-paroxetine combination.
Topics: Adult; Age Factors; Animals; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fe | 1997 |
Introduction: augmentation of antidepressant medication.
Topics: Anticonvulsants; Antidepressive Agents; Buspirone; Calcium Channel Blockers; Depressive Disorder; Dr | 1998 |
Antidepressant augmentation: conclusions and recommendations.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Synerg | 1998 |
Pindolol augmentation of antidepressant therapy.
Topics: Antidepressive Agents; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Humans; Pi | 1998 |
Brain noradrenergic receptors in major depression and schizophrenia.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Affinity Labels; Aged; Autoradiograph | 1999 |
Comparing time to onset of response in antidepressant clinical trials using the cure model and the Cramer-von Mises test.
Topics: Adrenergic beta-Antagonists; Algorithms; Antidepressive Agents; Antidepressive Agents, Second-Genera | 2000 |
Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies.
Topics: Adjuvants, Immunologic; Dehydroepiandrosterone; Depressive Disorder; Drug Therapy, Combination; Huma | 2000 |
Sympathomimetic effects of pindolol in depression.
Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Depressive Disorder; Drug Synergism; Hu | 2001 |
ECT-induced PRL release: a 5-HT1A-mediated event?
Topics: Adult; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Pindolol; | 1992 |
Early decrease in density of mononuclear leukocyte beta-adrenoceptors in depressed patients following amineptine treatment: possible relation to clinical efficiency.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Dibenzocycloheptenes; Female; Humans; Iodin | 1991 |
Beta-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bipolar Disorder; Depressive Disorder; Female; Humans; Mal | 1991 |
Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls.
Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder; Female; Humans; Iodocyanopindolol; Lymphocytes; | 1989 |
Decreased beta-adrenergic receptors in the leukocytes of depressed patients.
Topics: Adult; Depressive Disorder; Dexamethasone; Humans; Hydrocortisone; Iodine Radioisotopes; Leukocytes; | 1987 |
Lymphocyte beta-adrenergic receptor binding in panic disorder.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Agoraphobia; Depressive Disorder; Fear | 1988 |
Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation.
Topics: Depressive Disorder; Humans; In Vitro Techniques; Iodocyanopindolol; Lymphocytes; Pindolol; Psychomo | 1986 |